Business Details
28 Years
experience
Your Strategic Partner for HealthScience Communications
Oxford PharmaGenesis is an independent global HealthScience communications consultancy dedicated to accelerating the adoption of evidence-based innovations for patients in areas of unmet medical need. Founded in 1998, we have grown to become the largest independently owned and financed company in the healthcare communications sector, with over 500 talented professionals operating from offices and homes worldwide. Our mission drives every aspect of our work, ensuring clients receive strategic consultancy in medical communications, medical affairs, market access and value demonstration, health economics and outcomes research (HEOR), publications, patient engagement, artificial intelligence, and data science.We pride ourselves on our depth of expertise, innovative solutions, and commitment to quality, evidenced by our award-winning work and long-standing partnerships with eight of the top 10 global pharmaceutical companies. Our culture of collaboration, integrity, and humanity underpins our success, enabling us to deliver impactful solutions that align with our clients' goals while fostering a supportive environment for our people. As a socially responsible organisation, we actively engage in charitable initiatives driven by our colleagues, reflecting our dedication to making a positive difference in the world beyond our professional endeavours.
Services
Medical Communications
Medical Affairs
Market Access
Value Demonstration
Patient Engagement
AI and Data Science
Real-World Evidence
Publications
Health Economics
Policy Consultancy
Details
- Year established: 1998
Highlights and features
- We have over 25 years of experience in HealthScience communications
- Our team consists of certified experts with extensive industry knowledge
- We offer innovative solutions tailored to client needs
- We are an independent company committed to transparency and client success
- We have worked with eight of the top 10 global pharmaceutical companies for over five years
Services
Medical Communications
We provide strategic medical communications services to help clients convey complex scientific information effectively. Our expertise spans publication planning, medical writing, and multichannel communication strategies tailored to healthcare professionals and patients. With deep industry knowledge, we ensure compliance with regulatory standards while maximising the impact of medical messaging across global markets.
Real-World Evidence
Our real-world evidence services generate actionable insights from observational studies and patient data to support healthcare decision-making. We specialise in designing pragmatic clinical trials, conducting epidemiological research, and analysing real-world data to demonstrate treatment value. This evidence helps clients navigate regulatory pathways and market access challenges across diverse therapeutic areas.
Patient Engagement
We develop patient-centric strategies that integrate patient perspectives throughout the drug development lifecycle. Our services include patient journey mapping, co-creation of educational materials, and designing patient support programmes. By fostering meaningful patient engagement, we help clients improve treatment adherence, enhance clinical trial design, and build stronger relationships with patient communities.
AI and Data Science
Our AI and data science division leverages advanced analytics to transform healthcare data into strategic insights. We develop machine learning models for predictive analytics, implement natural language processing for medical literature reviews, and create data visualisation tools for complex datasets. These technologies enhance decision-making processes and optimise outcomes across medical affairs and market access initiatives.
Value Demonstration
We specialise in demonstrating therapeutic value through comprehensive health economic models and outcomes research. Our services include cost-effectiveness analysis, budget impact modelling, and quality-of-life assessments. By quantifying clinical benefits and economic value, we help clients secure market access and reimbursement for innovative therapies in competitive healthcare environments.
People
Chris Winchester
Chief Executive Officer
Chris Winchester leads Oxford PharmaGenesis with a vision to advance evidence-based healthcare solutions. Under his leadership, the company has grown into a global consultancy while maintaining its independent ethos. He champions innovation in medical communications and fosters a culture of excellence and social responsibility.
Questions
What services does Oxford PharmaGenesis offer?
We provide strategic consultancy in medical communications, medical affairs, market access, patient engagement, real-world evidence generation, AI and data science, and health economics.
How long has Oxford PharmaGenesis been in business?
We were founded in 1998 and have over 25 years of experience in HealthScience communications.
Do you work with international clients?
Yes, we operate globally with offices in Europe, North America, and Asia-Pacific, serving healthcare organisations worldwide.
What makes Oxford PharmaGenesis different?
Our independence, deep expertise, and commitment to innovation set us apart, along with our long-standing partnerships with top pharmaceutical companies.
How do you approach patient engagement?
We integrate patient perspectives throughout drug development, creating tailored strategies that improve treatment adherence and clinical trial design through meaningful patient collaboration.
Videos
Reviews (1)
Olivia Chappell
Jun 12, 2018
Report
An incredibly welcoming, positive and engaged bunch. It was a pleasure to work with a company filled with so much talent and enthusiasm.
